Trial intelligence / Profile preview

Dobutamine + nitroglycerin versus milrinone for perioperative pulmonary hypertension in mitral valve surgery

PACTR201710002685398Unknown

Sponsor
Faculty of Medicine, Menoufia University
Start
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of dobutamine, nitroglycerin and milrinone in pulmonary hypertension (PH) and mitral valve disease (2 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoint: Mean pulmonary artery pressure. Status: unknown.

02

Drugs

dobutaminenitroglycerinmilrinone
03

Conditions

pulmonary hypertension (PH)mitral valve disease

Beyond the preview

Go deeper on PACTR201710002685398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201710002685398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call